James Tyler Mills Jr, MD - Medicare Urology in Concord, NC

James Tyler Mills Jr, MD is a medicare enrolled "Urology" physician in Concord, North Carolina. He went to University Of Virginia School Of Medicine and graduated in 2013 and has 11 years of diverse experience with area of expertise as Urology. He is a member of the group practice Stone Institute Of The Carolinas Llc, Carolina Urology Partners Pllc and his current practice location is 1084 Vinehaven Dr Ne, Concord, North Carolina. You can reach out to his office (for appointments etc.) via phone at (704) 786-5131.

James Tyler Mills Jr is licensed to practice in North Carolina (license number 2019-01578) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1912240516.

Contact Information

James Tyler Mills Jr, MD
1084 Vinehaven Dr Ne,
Concord, NC 28025-2438
(704) 786-5131
(704) 784-4129



Physician's Profile

Full NameJames Tyler Mills Jr
GenderMale
SpecialityUrology
Experience11 Years
Location1084 Vinehaven Dr Ne, Concord, North Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • James Tyler Mills Jr attended and graduated from University Of Virginia School Of Medicine in 2013
  NPI Data:
  • NPI Number: 1912240516
  • Provider Enumeration Date: 04/02/2013
  • Last Update Date: 05/27/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 1456580299
  • Enrollment ID: I20190722002516

Medical Identifiers

Medical identifiers for James Tyler Mills Jr such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1912240516NPI-NPPES
2019-01578OtherNCNC MEDICAL BOARD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 2019-01578 (North Carolina)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Carolinas Medical Center-northeastConcord, NCHospital
Novant Health Mint Hill Medical CenterCharlotte, NCHospital
Stanly Regional Medical CenterAlbemarle, NCHospital
Carolinas Medical Center/behav HealthCharlotte, NCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Stone Institute Of The Carolinas Llc317341253332
Carolina Urology Partners Pllc892128058738

News Archive

Continuous circular cycling ‘a distinct bipolar disorder subtype'

Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.

Durata receives positive EMA Scientific Advice on dalbavancin clinical development plan

Durata Therapeutics today announced the Company has received positive Scientific Advice from the European Medicines Agency on the pivotal clinical development plan for dalbavancin, Durata's long-acting, intravenous lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

Prestigious journal suppressing dissenting evidence favoring unnecessary cervical biopsy industry, complains HiFi DNA Tech president

Connecticut Pathologist Sin Hang Lee, MD, has filed a complaint with the international Council of Science Editors alleging the prestigious New England Journal of Medicine (Journal) is suppressing dissenting evidence in favor of a $10 billion "unnecessary cervical biopsy industry that protects special interest groups."

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

Whittier Independent Practice Association, of Newburyport, Massachusetts, announced that it has signed an agreement with Alere Accountable Care Solutions to build a community-wide health information exchange.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. James Tyler Mills Jr allows following entities to bill medicare on his behalf.
Entity NameStone Institute Of The Carolinas Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457377954
PECOS PAC ID: 3173412533
Enrollment ID: O20040312001126

News Archive

Continuous circular cycling ‘a distinct bipolar disorder subtype'

Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.

Durata receives positive EMA Scientific Advice on dalbavancin clinical development plan

Durata Therapeutics today announced the Company has received positive Scientific Advice from the European Medicines Agency on the pivotal clinical development plan for dalbavancin, Durata's long-acting, intravenous lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

Prestigious journal suppressing dissenting evidence favoring unnecessary cervical biopsy industry, complains HiFi DNA Tech president

Connecticut Pathologist Sin Hang Lee, MD, has filed a complaint with the international Council of Science Editors alleging the prestigious New England Journal of Medicine (Journal) is suppressing dissenting evidence in favor of a $10 billion "unnecessary cervical biopsy industry that protects special interest groups."

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

Whittier Independent Practice Association, of Newburyport, Massachusetts, announced that it has signed an agreement with Alere Accountable Care Solutions to build a community-wide health information exchange.

Read more Medical News

› Verified 3 days ago

Entity NameCarolina Urology Partners Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013210004
PECOS PAC ID: 8921280587
Enrollment ID: O20110303000580

News Archive

Continuous circular cycling ‘a distinct bipolar disorder subtype'

Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.

Durata receives positive EMA Scientific Advice on dalbavancin clinical development plan

Durata Therapeutics today announced the Company has received positive Scientific Advice from the European Medicines Agency on the pivotal clinical development plan for dalbavancin, Durata's long-acting, intravenous lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

Prestigious journal suppressing dissenting evidence favoring unnecessary cervical biopsy industry, complains HiFi DNA Tech president

Connecticut Pathologist Sin Hang Lee, MD, has filed a complaint with the international Council of Science Editors alleging the prestigious New England Journal of Medicine (Journal) is suppressing dissenting evidence in favor of a $10 billion "unnecessary cervical biopsy industry that protects special interest groups."

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

Whittier Independent Practice Association, of Newburyport, Massachusetts, announced that it has signed an agreement with Alere Accountable Care Solutions to build a community-wide health information exchange.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James Tyler Mills Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
James Tyler Mills Jr, MD
1215 Lee St, Box 800719,
Charlottesville, VA 22908-0816

Ph: (434) 924-2150
James Tyler Mills Jr, MD
1084 Vinehaven Dr Ne,
Concord, NC 28025-2438

Ph: (704) 786-5131

News Archive

Continuous circular cycling ‘a distinct bipolar disorder subtype'

Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.

Durata receives positive EMA Scientific Advice on dalbavancin clinical development plan

Durata Therapeutics today announced the Company has received positive Scientific Advice from the European Medicines Agency on the pivotal clinical development plan for dalbavancin, Durata's long-acting, intravenous lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

Prestigious journal suppressing dissenting evidence favoring unnecessary cervical biopsy industry, complains HiFi DNA Tech president

Connecticut Pathologist Sin Hang Lee, MD, has filed a complaint with the international Council of Science Editors alleging the prestigious New England Journal of Medicine (Journal) is suppressing dissenting evidence in favor of a $10 billion "unnecessary cervical biopsy industry that protects special interest groups."

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

Whittier Independent Practice Association, of Newburyport, Massachusetts, announced that it has signed an agreement with Alere Accountable Care Solutions to build a community-wide health information exchange.

Read more News

› Verified 3 days ago


Urology Doctors in Concord, NC

David Uri Lipsitz, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 1084 Vinehaven Dr, Concord, NC 28025
Phone: 704-786-5131    Fax: 704-784-4129
Paige Nicole Keough,
Urology
Medicare: Medicare Enrolled
Practice Location: 1085 Ne Gateway Ct Ne, Concord, NC 28025
Phone: 704-707-2203    Fax: 704-707-2203
Tom Sledge Floyd Jr., M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1085 Ne Gateway Ct Ne, Ste 180, Concord, NC 28025
Phone: 704-707-2200    Fax: 704-707-2203
John Mclean Nordan, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 1084 Vinehaven Dr, Concord, NC 28025
Phone: 704-786-5131    Fax: 704-784-4129
Dr. Cameron Trent Blackman, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1084 Vinehaven Dr, Concord, NC 28025
Phone: 704-786-5134    Fax: 704-784-4129
Dr. Harrison Kuhn Rhee, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1085 Ne Gateway Ct, Suite 180, Concord, NC 28025
Phone: 704-707-2200    Fax: 704-707-2203
Dr. Richard Natale Ii, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1084 Vinehaven Dr, Concord, NC 28025
Phone: 704-786-5131    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.